twenty-six of 102 patients who had more than five episodes of vomiting were considered mcp-resistant and were randomized to receive mcp ( 100 mg ) plus placebo versus mcp plus dexamethasone ( dm ; 48 mg ) iv in a double-blind , crossover trial .
C0042963
vomiting
C0011777
dexamethasone